Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.74 |
| ▸ | MAPT | P10636 | 6/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.74 |
| ▸ | TP53 | P04637 | 5/20 | 0.74 |
| ▸ | HPGD | P15428 | 4/20 | 0.74 |
| ▸ | USP2 | O75604 | 4/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.68 |
| ▸ | RECQL | P46063 | 5/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.68 |
| ▸ | CD38 | P28907 | 4/20 | 0.68 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31326068 | 0.88 | MEN1 (0.72) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL18676308 | 0.88 | MEN1 (0.72) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL29826664 | 0.88 | MEN1 (0.72) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL29432477 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL290081 | 0.85 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL10335363 | 0.84 | MEN1 (0.79) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL31126017 | 0.83 | MAOA (0.64) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL1879631 | 0.83 | MEN1 (0.63) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| SCHEMBL24474083 | 0.81 | MEN1 (0.75) | MEN1KMT2ACYP3A4MAPTKDM4E | |
| Myricetin SCHEMBL19302 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935714-B2 | Compositions for sleeping disorders | Bright Future Pharmaceutical Laboratories (HK) | 2011-05-03 | — | — | US | disclosed |
| US-7935714-B2 | Compositions for sleeping disorders | Bright Future Pharmaceutical Laboratories (HK) | 2011-05-03 | — | — | US | disclosed |
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | CHAN HSIAO CHANG | 2009-05-14 | — | — | US | disclosed |
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | CHAN HSIAO CHANG | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | PER2, CRY1, CRY2 | MEN1 4015/4885KMT2A 353/4885CYP3A4 1899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.